![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5631|17|6|442-452
ISSN: 1566-5232
Source: Current Gene Therapy, Vol.17, Iss.6, 2018-03, pp. : 442-452
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CX3CR1 as a target for airways inflammation
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. :